TScan Therapeutics, Inc.TCRXNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P67
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202512.28%
202416.18%
202350.36%
2022-34.98%
2021-95.19%
2020-96.23%
20190.00%